Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 3
1989 1
1992 1
1998 1
1999 2
2001 5
2002 3
2003 1
2004 2
2005 7
2006 7
2007 8
2008 7
2009 2
2010 4
2011 10
2012 6
2013 14
2014 12
2015 10
2016 13
2017 12
2018 14
2019 27
2020 43
2021 34
2022 36
2023 9
Text availability
Article attribute
Article type
Publication date

Search Results

264 results
Results by year
Filters applied: . Clear all
Page 1
BRAF Gene and Melanoma: Back to the Future.
Ottaviano M, Giunta EF, Tortora M, Curvietto M, Attademo L, Bosso D, Cardalesi C, Rosanova M, De Placido P, Pietroluongo E, Riccio V, Mucci B, Parola S, Vitale MG, Palmieri G, Daniele B, Simeone E, On Behalf Of Scito Youth. Ottaviano M, et al. Among authors: vitale mg. Int J Mol Sci. 2021 Mar 27;22(7):3474. doi: 10.3390/ijms22073474. Int J Mol Sci. 2021. PMID: 33801689 Free PMC article. Review.
Commentary.
Vitale MG. Vitale MG. J Pediatr Orthop. 2018 Jul;38 Suppl 1:S20. doi: 10.1097/BPO.0000000000001173. J Pediatr Orthop. 2018. PMID: 29877941 No abstract available.
Integrated analysis of concomitant medications and oncological outcomes from PD-1/PD-L1 checkpoint inhibitors in clinical practice.
Cortellini A, Tucci M, Adamo V, Stucci LS, Russo A, Tanda ET, Spagnolo F, Rastelli F, Bisonni R, Santini D, Russano M, Anesi C, Giusti R, Filetti M, Marchetti P, Botticelli A, Gelibter A, Occhipinti MA, Marconcini R, Vitale MG, Nicolardi L, Chiari R, Bareggi C, Nigro O, Tuzi A, De Tursi M, Petragnani N, Pala L, Bracarda S, Macrini S, Inno A, Zoratto F, Veltri E, Di Cocco B, Mallardo D, Vitale MG, Pinato DJ, Porzio G, Ficorella C, Ascierto PA. Cortellini A, et al. Among authors: vitale mg. J Immunother Cancer. 2020 Nov;8(2):e001361. doi: 10.1136/jitc-2020-001361. J Immunother Cancer. 2020. PMID: 33154150 Free PMC article.
Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition.
Rogiers A, Pires da Silva I, Tentori C, Tondini CA, Grimes JM, Trager MH, Nahm S, Zubiri L, Manos M, Bowling P, Elkrief A, Papneja N, Vitale MG, Rose AAN, Borgers JSW, Roy S, Mangana J, Pimentel Muniz T, Cooksley T, Lupu J, Vaisman A, Saibil SD, Butler MO, Menzies AM, Carlino MS, Erdmann M, Berking C, Zimmer L, Schadendorf D, Pala L, Queirolo P, Posch C, Hauschild A, Dummer R, Haanen J, Blank CU, Robert C, Sullivan RJ, Ascierto PA, Miller WH Jr, Stephen Hodi F, Suijkerbuijk KPM, Reynolds KL, Rahma OE, Lorigan PC, Carvajal RD, Lo S, Mandala M, Long GV. Rogiers A, et al. Among authors: vitale mg. J Immunother Cancer. 2021 Jan;9(1):e001931. doi: 10.1136/jitc-2020-001931. J Immunother Cancer. 2021. PMID: 33468556 Free PMC article.
Single-agent anti-PD-1 or combined with ipilimumab in patients with mucosal melanoma: an international, retrospective, cohort study.
Dimitriou F, Namikawa K, Reijers ILM, Buchbinder EI, Soon JA, Zaremba A, Teterycz P, Mooradian MJ, Armstrong E, Nakamura Y, Vitale MG, Tran LE, Bai X, Allayous C, Provent-Roy S, Indini A, Bhave P, Farid M, Kähler KC, Mehmi I, Atkinson V, Klein O, Stonesifer CJ, Zaman F, Haydon A, Carvajal RD, Hamid O, Dummer R, Hauschild A, Carlino MS, Mandala M, Robert C, Lebbe C, Guo J, Johnson DB, Ascierto PA, Shoushtari AN, Sullivan RJ, Cybulska-Stopa B, Rutkowski P, Zimmer L, Sandhu S, Blank CU, Lo SN, Menzies AM, Long GV. Dimitriou F, et al. Among authors: vitale mg. Ann Oncol. 2022 Sep;33(9):968-980. doi: 10.1016/j.annonc.2022.06.004. Epub 2022 Jun 16. Ann Oncol. 2022. PMID: 35716907
Nivolumab in Combination with Stereotactic Body Radiotherapy in Pretreated Patients with Metastatic Renal Cell Carcinoma. Results of the Phase II NIVES Study.
Masini C, Iotti C, De Giorgi U, Bellia RS, Buti S, Salaroli F, Zampiva I, Mazzarotto R, Mucciarini C, Vitale MG, Bruni A, Lohr F, Procopio G, Caffo O, Nole F, Morelli F, Baier S, Buttigliero C, Ciammella P, Timon G, Fantinel E, Carlinfante G, Berselli A, Pinto C. Masini C, et al. Among authors: vitale mg. Eur Urol. 2022 Mar;81(3):274-282. doi: 10.1016/j.eururo.2021.09.016. Epub 2021 Oct 1. Eur Urol. 2022. PMID: 34602312 Clinical Trial.
Atezolizumab for the treatment of breast cancer.
Basile D, Pelizzari G, Vitale MG, Lisanti C, Cinausero M, Iacono D, Puglisi F. Basile D, et al. Among authors: vitale mg. Expert Opin Biol Ther. 2018 May;18(5):595-603. doi: 10.1080/14712598.2018.1469619. Epub 2018 May 8. Expert Opin Biol Ther. 2018. PMID: 29690797 Review.
Immunotherapy for older patients with melanoma: From darkness to light?
Iacono D, Vitale MG, Basile D, Pelizzari G, Cinausero M, Poletto E, Pascoletti G, Minisini AM. Iacono D, et al. Among authors: vitale mg. Pigment Cell Melanoma Res. 2021 May;34(3):550-563. doi: 10.1111/pcmr.12917. Epub 2020 Aug 18. Pigment Cell Melanoma Res. 2021. PMID: 32745351 Review.
Emerging PD-1/PD-L1 antagonists for the treatment of malignant melanoma.
Vanella V, Festino L, Vitale MG, Alfano B, Ascierto PA. Vanella V, et al. Among authors: vitale mg. Expert Opin Emerg Drugs. 2021 Jun;26(2):79-92. doi: 10.1080/14728214.2021.1901884. Epub 2021 Mar 19. Expert Opin Emerg Drugs. 2021. PMID: 33686894 Review.
264 results